市場調查報告書
商品編碼
935347

3D印刷製劑市場:各劑型·技術·地區市場,及COVID-19的影響分析 - 2027年為止的預測

3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Dosage Forms; Technology, and Geography

出版日期: | 出版商: The Insight Partners | 英文 175 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

3D印刷製劑的全球市場在2019年估算為2,852萬美金。該市場從2020年∼2027年間,預測將以9.1%的年複合成長率增長,2027年達到5,703萬美元的規模。

本報告提供全球3D印刷製劑市場的相關調查,提供市場趨勢和機會,成長及阻礙因素,劑型·技術·各地區的市場分析,產業形勢,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 要點

第3章 調查手法

第4章 市場形勢

  • 概況
  • PEST分析

第5章 主要市場動態

  • 市場成長要素
  • 阻礙市場要素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 世界市場收益預測與分析
  • 市場預測及分析:各地區
  • 主要企業的市場定位

第7章 市場分析:各劑型

  • 概況
  • 市場佔有率
  • 錠劑
  • 膠囊
  • 多藥植入物
  • 奈米粒子
  • 溶劑
  • 其他劑型

第8章 市場分析:各技術

  • 概況
  • 市場佔有率
  • 噴墨印刷
  • DIW(直接墨水寫入)
  • Zip Dose
  • 熱感噴墨印刷
  • 溶融物累積法
  • 粉體熔化成型技術法
  • 立體光刻技術(SLA)
  • 半固態擠出(SSE)

第9章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第10章 COVID-19全球大流行對市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 產業形勢

  • 概況
  • 市場參與企業的成長策略
  • 有機的開發
  • 無機的開發

第12章 企業簡介

  • GlaxoSmithKline plc.
  • Aprecia Pharmaceuticals, LLC.
  • AstraZeneca
  • FabRx Ltd
  • Merck KGaA
  • Cycle Pharmaceuticals
  • Tvasta
  • MSD

第13章 附錄

目錄
Product Code: TIPRE00010199

The 3D printed drugsmarket was valued at US$ 28.52 million in 2019 and is expected to grow at a CAGR of 9.1% from 2020 to 2027 to reach US$ 57.03 million by 2027.The factors driving the 3D printed drugsmarketgrowth include the increasing adoption of personalized medicines, extensive research and development activities, and growing prevalence of dysphagia. The illegal use of 3D printing for manufacturing of drugs hinders the growth of the market.

3D printed drugs are medications that are designed by 3D printing technique to provide safe and effective customized drugs to the individuals. These drugs have unitary porous structures that readily disperse in the mouth, thus ruling out the necessity to sallow high-dose medicines intact. It enables manufacturers to easily adjust the size, appearance, shape, and rate of the delivery of a wide array of medicines.The growth of 3D printed drugsmarket is prominently attributed to the increasing adoption of personalized medicines and extensively growing R&D activities related to 3D printing. The implementation of 3D-printing technology to create personalized drug therapies is providing some exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express interest in purchasing customized products or services. This demand will definitely lead to growth of the 3D printing market by 2027. Moreover, since the Precision Medicine's Initiative was released in the US in 2015, pharmaceutical research organizations have been pursuing the development of more tailored treatments to make medicines safer and more effective.

The advantages of 3D printing such as its ability to offer personalized medicine system with an automated control over drug dose and suitability for both low and high drug concentrations allow drug companies to attain boosted efficacy and adherence of drugs as well as focus on their brand longevity by expanding and capturing market share with other dosage forms. FabRx Ltd., completed the world's first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, in April 2020, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines. The technique of 3D printing drugs could help make the medication safer and more attractive to children.

The global 3D printed drugs marketis segmented bydosage form and technology. The 3D printed drugsmarket, by dosage form, is segmented intotablets, capsules, multi drug implant, nanoparticles, solutions, and other dosage forms.The tablet segment held the largest share of the market, and it is expected to register the highest CAGR in the market during the forecast period. Based on technology, the 3D printed drugsmarket is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, and stereolithography (SLA). The zip dose held the largest share of technology segment in the global market; moreover, it is expected to register the fastest CAGR during the forecast period.

A few of the essential primary and secondary sources referred while preparing this report are the Food and Drug Administration (FDA), World Health Organization (WHO),Organization for Economic Co-operation and Development, National Institutes of Health (NIH), and Centers for Disease Control and Prevention (CDC),among

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the 3D printed drugs market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global 3D printed drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global 3D Printed Drugs Market - By Dosage Forms
    • 1.3.2 Global 3D Printed Drugs Market - By Technology
    • 1.3.3 Global 3D Printed Drugs Market - By Geography

2. 3D Printed Drugs Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global 3D Printed Drugs Market - Market Landscape

  • 4.1 Overview
  • 4.2 Pest Analysis
    • 4.2.1 North America- PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis

5. Global 3D Printed Drugs market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Adoption of Personalized Drugs
    • 5.1.2 Increasing Prevalence of Dysphagia
  • 5.2 Market Restraints
    • 5.2.1 Usage of 3D Printing to Develop Illegal Drugs
  • 5.3 Market Opportunities
    • 5.3.1 Rising Awareness About the 3D Printing Technology
  • 5.4 Future Trends
    • 5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes
  • 5.5 Impact analysis

6. 3D Printed Drugs Market- Global Analysis

  • 6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis
  • 6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. 3D Printed Drugs Market Analysis - By Dosage Forms

  • 7.1 Overview
  • 7.2 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035, (%)
  • 7.3 Tablets
    • 7.3.1 Overview
    • 7.3.2 Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2027 (US$ Thousands)
    • 7.3.3 Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 7.4 Capsules
    • 7.4.1 Overview
    • 7.4.2 Capsules: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 7.5 Multi Drug Implant
    • 7.5.1 Overview
    • 7.5.2 Multi Drug Implant: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 7.6 Nanoparticles
    • 7.6.1 Overview
    • 7.6.2 Nanoparticles: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 7.7 Solutions
    • 7.7.1 Overview
    • 7.7.2 Solutions: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 7.8 Other Dosage Forms
    • 7.8.1 Overview
    • 7.8.2 Other Dosage Forms: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)

8. 3D Printed Drugs Market Analysis - By Technology

  • 8.1 Overview
  • 8.2 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)
  • 8.3 Inkjet Printing
    • 8.3.1 Overview
    • 8.3.2 Inkjet Printing: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • 8.4 Direct Write
    • 8.4.1 Overview
    • 8.4.2 Direct Write: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • 8.5 Zip Dose
    • 8.5.1 Overview
    • 8.5.2 Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2027 (US$ Thousands)
    • 8.5.3 Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • 8.6 Thermal Inkjet Printing
    • 8.6.1 Overview
    • 8.6.2 Thermal Inkjet: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • 8.7 Fused Deposition Modelling
    • 8.7.1 Overview
    • 8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 8.8 Powder Bed Printing
    • 8.8.1 Overview
    • 8.8.2 Powder Bed Printing: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 8.9 Stereolithography (SLA)
    • 8.9.1 Overview
    • 8.9.2 Stereolithography (SLA): 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • 8.10 Semi Solid Extrusion (SSE)
    • 8.10.1 Overview
    • 8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)

9. 3D Printed Drugs Market - Geographic Analysis

  • 9.1 North America: 3D Printed Drugs Market
    • 9.1.1 Overview
    • 9.1.2 North America: 3D Printed Drugs Market - Revenue and Forecast to 2027 (USD Thousands)
    • 9.1.3 North America: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
    • 9.1.4 North America: 3D Printed Drugs Market, by Dosage Forms, 2018-2027 (USD Thousands)
    • 9.1.5 North America: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
    • 9.1.6 North America: 3D Printed Drugs Market, by Technology, 2018-2027 (USD Thousands)
    • 9.1.7 North America: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.1.8 North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)
    • 9.1.9 US: 3D Printed Drugs Market - Revenue and Forecast (USD thousands)
      • 9.1.9.1 US: 3D Printed Drugs Market - Revenue and Forecast to 2027 (USD Thousands)
      • 9.1.9.2 US: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.1.9.3 US: 3D Printed Drugs Market, by Dosage Forms, 2018-2027 (USD Thousands)
      • 9.1.9.4 US: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.1.9.5 US: 3D Printed Drugs Market, by Technology, 2018-2027 (USD Thousands)
      • 9.1.9.6 US: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.1.10 Canada: 3D Printed Drugs Market - Revenue and Forecast (USD Thousands)
      • 9.1.10.1 Canada: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.1.10.2 Canada: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.1.10.3 Canada: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.1.11 Mexico: 3D Printed Drugs Market - Revenue and Forecast (USD thousands)
      • 9.1.11.1 Mexico: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.1.11.2 Mexico: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.1.11.3 Mexico: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
  • 9.2 Europe: 3D Printed Drugs Market
    • 9.2.1 Overview
    • 9.2.2 Europe: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
    • 9.2.3 Europe: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
    • 9.2.4 Europe: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.2.5 Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
    • 9.2.6 Germany: 3D Printed Drugs Market
      • 9.2.6.1 Germany: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.2.6.2 Germany: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.2.6.3 Germany: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.2.7 United Kingdom: 3D Printed Drugs Market
      • 9.2.7.1 United Kingdom: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.2.7.2 United Kingdom: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.2.7.3 United Kingdom: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.2.8 France: 3D Printed Drugs Market
      • 9.2.8.1 France: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.2.8.2 France: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.2.8.3 France: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.2.9 Italy: 3D Printed Drugs Market
      • 9.2.9.1 Italy: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.2.9.2 Italy: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.2.9.3 Italy: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.2.10 Spain: 3D Printed Drugs Market
      • 9.2.10.1 Spain: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.2.10.2 Spain: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.2.10.3 Spain: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
  • 9.3 Asia Pacific: 3D Printed Drugs Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
    • 9.3.3 Asia Pacific: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
    • 9.3.4 Asia Pacific: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.3.5 Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
    • 9.3.6 China: 3D Printed Drugs Market
      • 9.3.6.1 China: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.3.6.2 China: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.3.6.3 China: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.3.7 Japan: 3D Printed Drugs Market
      • 9.3.7.1 Japan: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.3.7.2 Japan: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.3.7.3 Japan: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.3.8 India: 3D Printed Drugs Market
      • 9.3.8.1 India: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.3.8.2 India: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.3.8.3 India: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.3.9 South Korea: 3D Printed Drugs Market
      • 9.3.9.1 South Korea: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.3.9.2 South Korea: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.3.9.3 South Korea: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.3.10 Australia: 3D Printed Drugs Market
      • 9.3.10.1 Australia: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.3.10.2 Australia: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.3.10.3 Australia: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
  • 9.4 Middle East & Africa: 3D Printed Drugs Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
    • 9.4.3 Middle East & Africa: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
    • 9.4.4 Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
    • 9.4.5 Saudi Arabia: 3D Printed Drugs Market
      • 9.4.5.1 Saudi Arabia: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.4.5.2 Saudi Arabia: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.4.5.3 Saudi Arabia: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.4.6 South Africa: 3D Printed Drugs Market
      • 9.4.6.1 South Africa: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.4.6.2 South Africa: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.4.6.3 South Africa: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.4.7 UAE: 3D Printed Drugs Market
      • 9.4.7.1 UAE: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.4.7.2 UAE: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.4.7.3 UAE: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
  • 9.5 South and Central America: 3D Printed Drugs Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
    • 9.5.3 South and Central America: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
    • 9.5.4 South and Central America: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.5.5 South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
    • 9.5.6 Brazil: 3D Printed Drugs Market
      • 9.5.6.1 Brazil: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.5.6.2 Brazil: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.5.6.3 Brazil: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)
    • 9.5.7 Argentina: 3D Printed Drugs Market
      • 9.5.7.1 Argentina: 3D Printed Drugs Market - Revenue and Forecast to 2035 (USD Thousands)
      • 9.5.7.2 Argentina: 3D Printed Drugs Market, by Dosage Forms, 2028-2035 (USD Thousands)
      • 9.5.7.3 Argentina: 3D Printed Drugs Market, by Technology, 2028-2035 (USD Thousands)

10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. 3D Printed Drugs Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 GlaxoSmithKline plc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Aprecia Pharmaceuticals, LLC.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AstraZeneca
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 Key Developments
  • 12.4 FabRx Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Merck KGaA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Cycle Pharmaceuticals
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Tvasta
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 MSD
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2027 (USD Thousands)
  • Table 2. North America 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 3. North America 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2027 (USD Thousands)
  • Table 4. North America 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 5. US 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2027 (USD Thousands)
  • Table 6. US 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 7. US 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2027 (USD Thousands)
  • Table 8. US 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 9. Canada 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 10. Canada 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 11. Mexico 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 12. Mexico 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 13. Europe 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 14. Europe 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 15. Germany 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 16. Germany 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 17. United Kingdom 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 18. United Kingdom 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 19. France 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 20. France 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 21. Italy 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 22. Italy 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 23. Spain 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 24. Spain 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 25. Asia Pacific 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 26. Asia Pacific 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 27. China 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 28. China 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 29. Japan 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 30. Japan 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 31. India 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 32. India 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 33. South Korea 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 34. South Korea 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 35. Australia 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 36. Australia 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 37. Middle East & Africa 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 38. Middle East & Africa 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 39. Saudi Arabia 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 40. Saudi Arabia 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 41. South Africa 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 42. South Africa 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 43. UAE 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 44. UAE 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 45. South and Central America 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035 (USD Thousands)
  • Table 46. South and Central America 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 47. Brazil 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 48. Brazil 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 49. Argentina 3D Printed Drugs Market, by Dosage Forms - Revenue and Forecast to 2035(USD Thousands)
  • Table 50. Argentina 3D Printed Drugs Market, by Technology - Revenue and Forecast to 2035 (USD Thousands)
  • Table 1. Organic Developments Done By Companies
  • Table 2. Inorganic Developments Done By Companies
  • Table 3. Glossary of Terms, 3D Printed Drugs market

LIST OF FIGURES

  • Figure 1. 3D Printed Drugs Market Segmentation
  • Figure 2. 3D Printed Drugs Segmentation, By Region
  • Figure 3. Global 3D Printed Drugs Market Overview
  • Figure 4. The Tablets Segment Held Largest Share Of Dosage Forms Segment In 3D Printed Drugs Market (US$ Thousands)
  • Figure 5. North America Is Expected to Show Remarkable Growth During the Forecast Period (US$ Thousands)
  • Figure 6. Global 3D Printed Drugs Market, By Geography (US$ Thousands)
  • Figure 7. Global 3D Printed Drugs Market, Industry Landscape
  • Figure 8. North America PEST Analysis
  • Figure 9. Europe PEST Analysis
  • Figure 10. Asia Pacific PEST Analysis
  • Figure 11. Middle East & Africa PEST Analysis
  • Figure 12. South & Central America PEST Analysis
  • Figure 13. 3D printed drugs market impact analysis of driver and restraints
  • Figure 14. Global 3D Printed Drugs Market- Revenue Forecast And Analysis - 2019- 2027 (US$ Mn)
  • Figure 15. Market Positioning Of Key Players In Global 3D Printed Drugs Market
  • Figure 16. 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035 (%)
  • Figure 17. Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2027 (US$ Thousands)
  • Figure 18. Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 19. Capsules: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 20. Multi Drug Implant: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 21. Nanoparticles: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 22. Solutions: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 23. Other Dosage Forms: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 24. 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)
  • Figure 25. Inkjet Printing: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 26. Direct Write: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 27. Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2027 (US$ Thousands)
  • Figure 28. Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 29. Thermal Inkjet: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 30. Fused Deposition Modelling:3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 31. Powder Bed Printing: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 32. Stereolithography: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 33. Semi Solid Extrusion (SSE): 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
  • Figure 34. North America: 3D Printed Drugs Market, by Key Country - Revenue (2019) (USD Thousands)
  • Figure 35. North America: 3D Printed Drugs Market, by Key Country - Revenue (2035) (USD Thousands)
  • Figure 36. North America 3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 37. North America 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 38. North America: 3D Printed Drugs Market, by Country, 2028& 2035 (%)
  • Figure 39. US3D Printed Drugs Market Revenue and Forecast to 2027 (USD Thousands)
  • Figure 40. US3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 41. Canada3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 42. Mexico3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 43. Europe: 3D Printed Drugs Market, by Key Country - Revenue (2028) (USD Thousands)
  • Figure 44. Europe3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 45. Europe: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
  • Figure 46. Germany 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 47. United Kingdom3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 48. France3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 49. Italy3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 50. Spain3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 51. Asia Pacific: 3D Printed Drugs Market, by Key Country - Revenue (2028) (USD Thousands)
  • Figure 52. Asia Pacific3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 53. Asia Pacific: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
  • Figure 54. China 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 55. Japan3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 56. India3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 57. South Korea3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 58. Australia3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 59. Middle East & Africa: 3D Printed Drugs Market, by Key Country - Revenue (2028) (USD Thousands)
  • Figure 60. Middle East & Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 61. Middle East & Africa: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
  • Figure 62. Saudi Arabia 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 63. South Africa3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 64. UAE3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 65. South and Central America: 3D Printed Drugs Market, by Key Country - Revenue (2028) (USD Thousands)
  • Figure 66. South and Central America3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 67. South and Central America: 3D Printed Drugs Market, by Country, 2028 & 2035 (%)
  • Figure 68. Brazil 3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 69. Argentina3D Printed Drugs Market Revenue and Forecast to 2035 (USD Thousands)
  • Figure 70. Impact of COVID-19 Pandemic In North American Country Markets
  • Figure 71. Impact of COVID-19 Pandemic In European Country Markets
  • Figure 72. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 73. Impact Of COVID-19 Pandemic In North American Country Market
  • Figure 74. Growth Strategies Done by the Companies in the Market, (%)